Bausch & Lomb, Akorn Warned Over Unapproved Eye Drugs
The U.S. Food and Drug Administration on Tuesday revealed warning letters it sent to eye care companies Bausch & Lomb Inc. and Akorn Inc. last week, claiming they marketed ophthalmic drugs...To view the full article, register now.
Already a subscriber? Click here to view full article